Red light therapy
Supported by researchWhy it might help
Localized red or near-infrared light is proposed to influence mitochondrial signaling, local circulation, inflammatory mediators, and pain signaling in jaw muscles and joint tissues. These are plausible mechanisms, not proof that every device or dose will help.
What the research shows
A 2018 systematic review and meta-analysis of 31 randomized placebo-controlled trials in people with myogenous or joint-related TMD found that targeted low-level laser therapy favored short-term pain relief and jaw function, but study protocols were highly heterogeneous and long-term pain did not differ from placebo. A 2025 systematic review of 44 randomized trials involving 1,816 people with TMD also reported lower pain and improved mouth opening, while noting substantial variation in wavelengths, doses, and treatment schedules. This supports clinician-targeted low-level laser as a symptom-relief adjunct; it does not establish equivalent benefit from untargeted consumer or full-body red-light panels.
Sources & what they found (2)
Low-Level Laser Therapy for Temporomandibular Disorders: A Systematic Review with Meta-Analysis — Pain Research and Management (via PMC), 2018
Systematic review and meta-analysis of 31 randomized placebo-controlled trials; pooled findings favored short-term pain relief and jaw function, with high protocol heterogeneity and no clear long-term pain advantage.
Effectiveness of low-level laser therapy on temporomandibular disorders. A systematic review of randomized clinical trials — Photodiagnosis and Photodynamic Therapy (via PubMed), 2025
Systematic review of 44 randomized clinical trials involving 1,816 participants with TMD; reported improvements in pain and mandibular opening while identifying variability in treatment parameters as a limitation.
